Back

A novel viral protein translation mechanism reveals mitochondria as a target for antiviral drug development

Cheng, Z.; Zhang, D.; Chen, J.; Wu, Y.; Liu, X.; Si, L.; Zhang, Z.; Zhang, N.; Zhang, Z.; Liu, W.; Liu, H.; Zhang, L.; Song, L.; Dunmall, L. S. C.; Dong, J.; Lemoine, N. R.; Wang, Y.

2020-10-19 microbiology
10.1101/2020.10.19.344713 bioRxiv
Show abstract

The ongoing Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) pandemic has acutely highlighted the need to identify new treatment strategies for viral infections. Here we present a pivotal molecular mechanism of viral protein translation that relies on the mitochondrial translation machinery. We found that rare codons such as Leu-TTA are highly enriched in many viruses, including SARS-CoV-2, and these codons are essential for the regulation of viral protein expression. SARS-CoV-2 controls the translation of its spike gene by hijacking host mitochondria through 5 leader and 3UTR sequences that contain mitochondrial localization signals and activate the EGR1 pathway. Mitochondrial-targeted drugs such as lonidamine and polydatin significantly repress rare codon-driven gene expression and viral replication. This study identifies an unreported viral protein translation mechanism and opens up a novel avenue for developing antiviral drugs. One Sentence SummaryMitochondria are a potential target for antiviral therapy

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.